Hardwick et al. [73] recently reported elevated GPR75 expression in hepatocellular carcinoma (HCC) samples, despite decreased 20-HETE levels, suggesting that inflammatory responses and the tumor microenvironment in HCC may upregulate GPR75 expression via alternative pathways. The gene discussed is GPR75; the disease is hepatocellular carcinoma.